Calendar
How Cancer Cells Hijack a Germ Cell Restricted Protein, SYCP1, to Survive and Grow
What is essential for normal development can become harmful when activated in the wrong context. SYCP1 is a striking example. Normally, SYCP1 plays an important role in the formation of
Breakthrough Study Led by Dr Alan Prem Kumar Offers New Hope for Triple-Negative Breast Cancer Treatment
Dr Alan Prem Kumar and his team, have discovered a way to turn off the “master switch” driving aggressive triple-negative breast cancer. By targeting the DP103 gene with a drug
DNA Methylation Reveals Hidden Differences Between Two Aggressive T/NK Lymphomas
Extranodal NK/T-cell lymphoma (ENKTL) and EBV-positive nodal T/NK-cell lymphoma (nodal-TNKL) are rare, aggressive lymphomas that can share overlapping clinical and pathological features but have distinct underlying biology. Understanding these differences
Personalising Treatment for Aggressive Ovarian Cancer
High-grade serous ovarian cancer (HGSOC) is the most common and one of the most aggressive forms of ovarian cancer. Within HGSOC, the Mesenchymal and Stem-like A subtypes are often associated
Targeting RNA Regulation to Help the Immune System Fight Cancer
Our cells have built-in safeguards that help the immune system distinguish the body’s own RNA from foreign RNA, such as RNA produced during a viral infection. Cancer cells can take
How Sugar-Processing Proteins May Support Cancer Growth
Cancer cells change how they use sugar to support their rapid growth. Using yeast as a laboratory model, researchers found that two proteins involved in processing sugar may also influence
director's foreword
Bringing N2CR to Greater Heights
The National University of Singapore’s Centre for Cancer Research (N2CR) was established in 2020 as one of ten Translational Research Programmes under the Yong Loo Lin School of Medicine. As the largest of these programmes, N2CR brings together more than 100 faculty members spanning basic, translational, and clinical sciences — united by a shared vision to advance cancer research and improve patient outcomes.
Professor Goh Boon Cher
Director, NUS Centre for Cancer Research (N2CR)
Translational Research Programme, Yong Loo Lin School of Medicine
National University of Singapore
OUR VISION AND MISSION
of the N2CR is simple
To develop innovative new ways to detect, cure or prevent cancer.
The hallmark of
The Programme
SCOUT
– Decoding Cancer’s Beginnings for Healthier Tomorrow
Theme Leads
Dr OOI Gaik Ming, Melissa
Dr CHEOK Chit Fang
COMPASS
– Charting the Future of Precision Oncology
The COMPASS theme unites a diverse community of basic and clinical cancer scientists to advance customised oncology. By integrating molecular profiling for strategic patient selection and enabling technologies for new treatment modalities, COMPASS builds a collaborative platform to discover mechanisms, refine therapies and accelerate precision medicine with a focus on Asian-specific tumour types.
Theme Leads
Dr TAY Kai Xun, Joshua
Dr Dennis KAPPEI
some of our trending
News & Events
Discover what matters to you the most.
How Cancer Cells Hijack a Germ Cell Restricted Protein, SYCP1, to Survive and Grow
Aug 26, 2026
Breakthrough Study Led by Dr Alan Prem Kumar Offers New Hope for Triple-Negative Breast Cancer Treatment
Aug 24, 2026
DNA Methylation Reveals Hidden Differences Between Two Aggressive T/NK Lymphomas
Aug 21, 2026
Personalising Treatment for Aggressive Ovarian Cancer
Aug 17, 2026
Targeting RNA Regulation to Help the Immune System Fight Cancer
Aug 12, 2026
Breakthrough Study Led by Dr Alan Prem Kumar Offers New Hope for Triple-Negative Breast Cancer Treatment
Aug 24, 2026
New CAR T-Cell Therapy Offers Hope for Relapsed or Refractory T-cell Leukaemia
Oct 9, 2024
Prof Ashok’s message on World Cancer Day 2024
Feb 7, 2024
A/Prof Alfredo Franco-Obregon and Dr Joline Lim on CNA’s On The Pulse
May 18, 2023
A/Prof Polly Chen is nominated as the RNA Society’s Asian Research Ambassador
Apr 28, 2023
Giving
Your Gift, Our Breakthroughs
Your generosity fuels our mission to advance cancer research and nurture future scientists. By giving to N2CR, you drive discoveries, support researchers, and strengthen collaborations that bring us closer to better treatments. Every gift, no matter the size, makes a meaningful impact in the fight against cancer.
be part of us
Find The Best Positions For You
Join us and be a part in shaping Singapore's healthcare for the future!